N-Acetyl GD3
General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference32 reference for EP0062
sort by year ∧ ∨ | Reference detail |
---|---|
1 | Kotani M, Terashima T, Tai T. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 1995 Nov 27;700(1-2):40-58 PMID: 8624728 |
2 | Kawashima I, Nagata I, Tai T. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732(1-2):75-86 PMID: 8891271 |
3 | Kotani M, Kawashima I, Ozawa H, Ogura K, Ishizuka I, Terashima T, Tai T. Immunohistochemical localization of minor gangliosides in the rat central nervous system. Glycobiology. 1994 Dec ;4(6):855-65 PMID: 7734848 |
4 | Kawashima I, Ozawa H, Kotani M, Suzuki M, Kawano T, Gomibuchi M, Tai T. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J Biochem (Tokyo). 1993 Aug ;114(2):186-93 PMID: 8262898 |
5 | Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65 PMID: 15464996 |
6 | Ozawa H, Kotani M, Kawashima I, Tai T. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jan 24;1123(2):184-90 PMID: 1371229 |
7 | Zenita K, Hirashima K, Shigeta K, Hiraiwa N, Takada A, Hashimoto K, Fujimoto E, Yago K, Kannagi R. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J Immunol. 1990 Jun 1;144(11):4442-51 PMID: 2111348 |
8 | Cheresh DA, Harper JR, Schulz G, Reisfeld RA. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci U S A. 1984 Sep ;81(18):5767-71 PMID: 6385004 |
9 | Welte B, Handgretinger R, Rassner G, Fierlbeck G. Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma. Exp Dermatol. 1997 Apr ;6(2):64-9 PMID: 9209886 |
10 | Tai T, Kawashima I, Tada N, Dairiki K. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2. J Biochem (Tokyo). 1988 Apr ;103(4):682-7 PMID: 3170507 |
11 | Fukuta S, Werkmeister JA, Burns GF, Ginsburg V, Magnani JL. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides. J Biol Chem. 1987 Apr 5;262(10):4800-3 PMID: 2435716 |
12 | Werkmeister JA, Triglia T, Mackay IR, Dowling JP, Varigos GA, Morstyn G, Burns GF. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3. Cancer Res. 1987 Jan 1;47(1):225-30 PMID: 3791209 |
13 | Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med. 1982 Apr 1;155(4):1133-47 PMID: 7061953 |
14 | Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res. 1989 Jan 1;49(1):191-6 PMID: 2908845 |
15 | Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci U S A. 1987 Apr ;84(8):2416-20 PMID: 3031684 |
16 | Tai T, Kawashima I, Furukawa K, Lloyd KO. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3. Arch Biochem Biophys. 1988 Jan ;260(1):51-5 PMID: 2449128 |
17 | Brodin T, Hellstrom I, Hellstrom KE, Karlsson KA, Sjogren HO, Stromberg N, Thurin J. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside. Biochim Biophys Acta. 1985 Dec 4;837(3):349-53 PMID: 3840699 |
18 | Watarai S, Onuma M, Yasuda T. Production of monoclonal antibodies specific for ganglioside GD3. J Biochem (Tokyo). 1991 Dec ;110(6):889-95 PMID: 1724444 |
19 | He X, Wikstrand CJ, Fredman P, Mansson JE, Svennerholm L, Bigner DD. GD3 expression by cultured human tumor cells of neuroectodermal origin. Acta Neuropathol (Berl). 1989 ;79(3):317-25 PMID: 2609939 |
20 | Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Res. 1986 Oct ;46(10):5112-8 PMID: 3019521 |
21 | Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol. 1986 Mar ;102(3):688-96 PMID: 3005335 |
22 | Hedberg KM, Mahesparan R, Read TA, Tysnes BB, Thorsen F, Visted T, Bjerkvig R, Fredman P. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains. Neuropathol Appl Neurobiol. 2001 Dec ;27(6):451-64 PMID: 11903928 |
23 | Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE, Smereczynska M, Karlsson KA, Clark WM Jr, Steplewski Z, et al. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res. 1987 Mar 1;47(5):1229-33 PMID: 3815333 |
24 | Hildebrandt H. Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample. FEBS Lett. 1996 Jun 10;388(1):29-33 PMID: 8654583 |
25 | Townson K, Greenshields KN, Veitch J, Nicholl D, Eckhardt M, Galanina O, Bovin N, Samain E, Antoine T, Bundle D, Zhang P, Ling CC, Willison HJ. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov ;17(11):1156-66 PMID: 17855742 |
26 | Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999 Sep ;104(6):697-708 PMID: 10491405 |
27 | Willison HJ, Townson K, Veitch J, Boffey J, Isaacs N, Andersen SM, Zhang P, Ling CC, Bundle DR. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 2004 Mar ;127(Pt 3):680-91 PMID: 14960498 |
28 | Boffey J, Nicholl D, Wagner ER, Townson K, Goodyear C, Furukawa K, Furukawa K, Conner J, Willison HJ. Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol. 2004 Jul ;152(1-2):98-111 PMID: 15223242 |
29 | Boffey J, Odaka M, Nicoll D, Wagner ER, Townson K, Bowes T, Conner J, Furukawa K, Willison HJ. Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 2005 Aug ;165(1-2):92-103 PMID: 15967512 |
30 | Miyazaki H, Shiku H, Furukawa K. Differential effects of a murine monoclonal antibody reactive with the disialylgalactosyl residue on the growth of melanoma cells and T cell activation. Int J Oncol. 1996 Aug ;9(2):241-5 PMID: 21541506 |
31 | Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R, Tai T. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas. Int J Cancer. 1988 Feb 15;41(2):267-74 PMID: 2448252 |
32 | Dippold WG, Lloyd KO, Li LT, Ikeda H, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1980 Oct ;77(10):6114-8 PMID: 6934537 |